HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effectiveness of humanized anti-interleukin-6 receptor antibody (tocilizumab) for Castleman's disease mainly with pulmonary involvement].

AuthorsNobuhito Ohno, Sayuri Fujiyama, Masaomi Ooi, Kouichi Haraguchi, Masahito Tokunaga, Kimiharu Uozumi, Hirohito Tsubouchi
JournalNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine (Nihon Naika Gakkai Zasshi) Vol. 96 Issue 5 Pg. 988-90 (May 10 2007) ISSN: 0021-5384 [Print] Japan
PMID17564092 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • tocilizumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Castleman Disease (drug therapy)
  • Humans
  • Lung Diseases (drug therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: